Targeted next-generation sequencing extends the phenotypic and mutational spectrums for EYS mutations. 2016

Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, State Key Laboratory of Reproductive Medicine, Nanjing, China.

We aim to determine genetic lesions with a phenotypic correlation in four Chinese families with autosomal recessive retinitis pigmentosa (RP). Medical histories were carefully reviewed. All patients received comprehensive ophthalmic evaluations. The next-generation sequencing (NGS) approach targeting a panel of 205 retinal disease-relevant genes and 15 candidate genes was selectively performed on probands from the four recruited families for mutation detection. Online predictive software and crystal structure modeling were also applied to test the potential pathogenic effects of identified mutations. Of the four families, two were diagnosed with RP sino pigmento (RPSP). Patients with RPSP claimed to have earlier RP age of onset but slower disease progression. Five mutations in the eyes shut homolog (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causative in the four families. The missense variant c.5093T>C was determined to be a variant of unknown significance (VUS) due to the variant's colocalization in the same allele with the reported pathogenic mutation c.6416G>A. The two novel variants were further confirmed absent in 100 unrelated healthy controls. Online predictive software indicated potential pathogenicity of the three missense mutations. Further, crystal structural modeling suggested generation of two abnormal hydrogen bonds by the missense mutation p.G2186E (c.6557G>A) and elongation of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertiary structure of the eys protein and thus interrupt its physicochemical properties. Taken together, with the targeted NGS approach, we reveal novel EYS mutations and prove the efficiency of targeted NGS in the genetic diagnoses of RP. We also first report the correlation between EYS mutations and RPSP. The genotypic-phenotypic relationship in all Chinese patients carrying mutations in the EYS gene were also reviewed and summarized.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004596 Electroretinography Recording of electric potentials in the retina after stimulation by light. Electroretinographies
D005136 Eye Proteins PROTEINS derived from TISSUES of the EYE. Proteins, Eye
D005260 Female Females
D005808 Genes, Recessive Genes that influence the PHENOTYPE only in the homozygous state. Conditions, Recessive Genetic,Genetic Conditions, Recessive,Recessive Genetic Conditions,Condition, Recessive Genetic,Gene, Recessive,Genetic Condition, Recessive,Recessive Gene,Recessive Genes,Recessive Genetic Condition

Related Publications

Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
January 2019, Molecular vision,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
April 2016, Scientific reports,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
March 2015, Scientific reports,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
November 2019, Acta Cardiologica Sinica,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
September 2011, Genome medicine,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
November 2020, Genetic testing and molecular biomarkers,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
January 2017, PloS one,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
February 2015, BMC medical genetics,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
January 2016, Neuromuscular disorders : NMD,
Shun Gu, and Yuanyuan Tian, and Xue Chen, and Chen Zhao
January 2017, PloS one,
Copied contents to your clipboard!